Stomach Neoplasms: all 2,914 studies
Page 15 of 30. Open to participants first (880), then studies with results posted, then the rest; newest registration first within each.
- Clinical Study of 68Ga Labeled HER2 Affibody AnaloguesStatus unknownNCT05411432Early Phase 1
- Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer PatientsCompletedNCT05411133Phase 1
- Nab-paclitaxel Plus Camrelizumab and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer CellsStatus unknownNCT05410847Phase 2
- To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After GasterectomyCompletedNCT05410535Phase 4
- Effect of a Self-designed MET Exercise Intervention on Cancer-related Fatigue in Patients With Gastric CancerCompletedNCT05401045Not applicable
- Two-Part, Phase Ib/II, Open Label, Single-Arm, Multi-center Study to Evaluate the Safety and Efficacy of Varlitinib in Combination With Weekly Paclitaxel in EGFR/HER2 Co-expressing Advanced or Metastatic Gastric Cancer PatientsCompletedNCT05400915Phase 1/2
- Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in CancerSuspendedNCT05400122Phase 1
- Use of Circulating Exosomal LncRNA-GC1 to Monitor Gastric CancerStatus unknownNCT05397548
- Handgrip Strength (HGS) With HGS Asymmetry Are Associated With All-cause Mortality and Hospital ReadmissionsCompletedNCT05397444
- A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid TumorsCompletedNCT05396300Phase 1
- A Phase 2 Study to Evaluate the Safety and Efficacy of Max-40279-01 in Patients With Advanced Gastric Cancer or Gastroesophageal Junction CancerStatus unknownNCT05395780Phase 2
- Immune Combined Targeted and Chemotherapy in Perioperative Treatment of Locally Advanced Gastric CancerStatus unknownNCT05385900Not applicable
- A Retrospective Study of Immunotherapy in Conversion Therapy of Unresectable Gastric CancerStatus unknownNCT05385809
- Concomitant Intraperitoneal and Systemic Chemotherapy in Patients With Extensive Peritoneal Carcinomatosis of Gastric OriginCompletedNCT05379790Phase 1
- A Study of exoASO-STAT6 (CDK-004) in Patients With Advanced Hepatocellular Carcinoma (HCC) and Patients With Liver Metastases From EIther Primary Gastric Cancer or Colorectal Cancer (CRC)TerminatedNCT05375604Phase 1
- A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic CancersCompletedNCT05360680Phase 1
- The Effect of Chemoradiotherapy on Gastric Perfusion in Patients With Gastric Cancer.TerminatedNCT05354856Phase 4
- Multimodal Prehabilitation To Improve The Clinical Outcomes Of Frail Elderly Patients With Gastric CancerActive, not recruitingNCT05352802Not applicable
- The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Gastric CancerStatus unknownNCT05351398
- Dynamic Multiomics Evaluation of Anti-HER2 and Immunotherapy in HER2 Positive Gastric CancerStatus unknownNCT05348161Not applicable
- Development of Free DNA Multi-target Methylated PCR for Auxiliary Diagnosis of Gastric CancerCompletedNCT05336058
- Prospectively Predict the Immunotherapy Response of Gastric Cancer Based on Circulating Exosomal LncRNA-GC1 BiopsyCompletedNCT05334849
- A Study of the Effectiveness and Safety of Nivolumab Plus Chemotherapy in Participants With Untreated Advanced/Recurrent Gastric CancerCompletedNCT05334719
- A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract MalignanciesCompletedNCT05329766Phase 2
- A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.TerminatedNCT05322577Phase 1/2
- RC48 Plus AK105 and Cisplatin in Advanced Gastric CancerStatus unknownNCT05313906Phase 2
- Study of HLX10, Trastuzumab and Chemotherapy in First-line Treatment of HER2-positive Recurrent/Metastatic Gastric CancerStatus unknownNCT05311189Phase 2
- Development and Validation of a Web-based Nomorgam to Predict Postoperative ComplicationsCompletedNCT05301699
- Predictive Role of Circulating Angiogenic Factors for Second-line Paclitaxel and Ramucirumab.Status unknownNCT05301465
- Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric CancersWithdrawnNCT05296005Phase 1
- Retrospective Study of Effect of Adjuvant Chemoradiation of Gastric Carcinoma on Local Control and SurvivalStatus unknownNCT05287672
- VITAMin Insufficiency in Esophagogastric NeoplasmsCompletedNCT05281380Not applicable
- Specialization in Gastric Cancer SurgeryCompletedNCT05280665
- Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal CancerActive, not recruitingNCT05277766Phase 1
- First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid TumorsActive, not recruitingNCT05277051Phase 1
- Study to Evaluate the Safety and Efficacy of Tislelizumab in Combination With Zanidatamab as a 2nd Line in HER2-Positive Advanced Gastric Cancer in K-Umbrella TrialStatus unknownNCT05270889Phase 2
- Early Detection of Gastric Cancer Using Plasma Cell-free DNA FragmentomicsStatus unknownNCT05269056
- Learning Curve for Gastric Endoscopic Submucosal DissectionCompletedNCT05265221
- Preoperative Immunonutrition in Laparoscopic Total D2 GastrectomyCompletedNCT05259488
- D1 vs D2 Lymphadenectomy in Gastric CancerCompletedNCT05253430
- (VELA) Study of BLU-222 in Advanced Solid TumorsTerminatedNCT05252416Phase 1
- HLX07+HLX10+Chemotherapy or HLX07 Monotherapy in Patients With Advanced Metastatic Gastric CancerStatus unknownNCT05246982Phase 2
- P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid TumorsActive, not recruitingNCT05239143Phase 1
- A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid TumorsActive, not recruitingNCT05238883Phase 1
- Total Versus Partial Omentectomy in the Treatment of Gastric CancerStatus unknownNCT05238584Not applicable
- PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid TumorsTerminatedNCT05233436Phase 1
- A Study of SGN-ALPV in Advanced Solid TumorsTerminatedNCT05229900Phase 1
- Effect of CNSI vs. ICG in Lymph Node Tracing During GastrectomyActive, not recruitingNCT05229874Phase 2
- Clinical Trial of Yiqi Wenyang Jiedu Prescription in the Prevention and Treatment of Postoperative Metastasis and Recurrence of Gastric CancerStatus unknownNCT05229809Phase 4
- Conversion Therapy of Hyperthermic Intraperitoneal Chemotherapy Plus Chemotherapy and Chemotherapy in Stage IV Gastric CancerStatus unknownNCT05228743Not applicable
- Early Detection of Five Common Cancers Using the ctDNA Analysing TestCompletedNCT05227261
- AssesSment of Early-deteCtion basEd oN liquiD Biopsy in GASTRIC Cancer, ASCEND-GastricStatus unknownNCT05224596
- Tislelizumab Combined With Apatinib and Oxaliplatin Plus S1 as Neoadjuvant Therapy for Borrmann IV、Large Borrmann III Type and Bulky N Positive Advanced Gastric CancerCompletedNCT05223088Phase 2
- Safety of XELOX Combined With GLS-010 and Lenvatinib in Advanced AFP-positive Gastric Cancer PatientsStatus unknownNCT05221775Phase 1
- Questionnaire Survey of the Advanced Training Program for Laparoscopic Radical GastrectomyCompletedNCT05219539
- Detection of CTC and ctDNA in the Diagnosis of Metastasis in Gastric CancerStatus unknownNCT05208372
- Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI CancersActive, not recruitingNCT05205330Phase 1/2
- Gut Microbiota and MetabonomicsStatus unknownNCT05205187
- Efficacy and Safety of Sintilimab Combined Intraperitoneal and Intravenous Paclitaxel Plus Oral S-1 in Gastric Cancer Patients With Peritoneal MetastasisStatus unknownNCT05204173Phase 2
- Telehealth for the Self-Management of Dietary Quality of Life in Patients After Stomach Cancer SurgeryActive, not recruitingNCT05203627Not applicable
- Consistency Between Treatment Responses in PDO Models and Clinical Outcomes in Gastric CancerStatus unknownNCT05203549
- Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GCStatus unknownNCT05198856Phase 1/2
- Cinrebafusp Alfa in Combination With Ramucirumab and Paclitaxel in HER2-High Gastric or GEJ Adenocarcinoma and in Combination With Tucatinib in HER2-Low Gastric or GEJ AndenocarinomaActive, not recruitingNCT05190445Phase 2
- A Study to Evaluate the Efficacy and Safety of MRG003 in Patients With Advanced Gastric Cancer.TerminatedNCT05188209Phase 2
- Predictive Factors of Morbidity and Mortality and Overall Survival of Patients With Gastric Cancer : a Case SeriesCompletedNCT05186402
- Phase 1/2a Study to Evaluate FL-301 in Patients With Advanced Solid TumorsWithdrawnNCT05181865Phase 1/2
- Long-term Oncologic Outcomes of Robotic Versus Laparoscopic Total Gastrectomy for Advanced Gastric CancerCompletedNCT05181306
- Tempus Priority Study: A Pan-tumor Observational StudyActive, not recruitingNCT05179824
- Conversion Therapy of Fruquintinib in Combination With Sintilimab and SOX in Unresectable Gastric CancerActive, not recruitingNCT05177068Phase 2
- Effects of BIS Closed Loop Target Controlled Infusion on Perioperative Inflammatory Response and Prognosis of Elderly Patients Undergoing Laparoscopic Radical Gastrectomy for Gastric CancerCompletedNCT05173909Not applicable
- A Phase Ib/II Clinical Study Evaluating HMPL-453 Tartrate as Monotherapy and in Combination With Chemotherapy or Toripalimab in Advanced Solid TumorsCompletedNCT05173142Phase 1/2
- Lenvatinib With Taxane Drugs Treatment for Advanced Gastric CancerStatus unknownNCT05171530Phase 1
- Evaluation of HER2-targeted Therapy for Gastric Cancer and Establishment and Verification of Monitoring SystemStatus unknownNCT05165602
- A Study of Nivolumab Plus Chemotherapy in First Line Treatment of Adult Participants With Advanced or Metastatic Gastric CancerActive, not recruitingNCT05165264
- Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric CancerTerminatedNCT05161572Phase 2
- Laparoscopic Gastric Function Preserving Surgery Combined With Resection of the Anterior Lymphatic Drainage AreaStatus unknownNCT05160753Not applicable
- First in Human Study of TORL-2-307-ADC in Participants With Advanced CancerActive, not recruitingNCT05156866Phase 1
- A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal CancersActive, not recruitingNCT05152147Phase 3
- A Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)Active, not recruitingNCT05144854Phase 3
- A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid TumorsActive, not recruitingNCT05143970Phase 1
- A Study of MRG002 in the Treatment of HER2-positive/HER2-low Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer.Status unknownNCT05141747Phase 2
- The Impact of COVID-19 Pandemic on Clinical Presentation and Staging of Gastric CancerCompletedNCT05130710
- Gastric Cancer Survival Without ChemotherapyCompletedNCT05125614
- Disitamab Vedotin Combined With PD-1 and Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer（RC48-C018）Status unknownNCT05113459Phase 2
- Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for FGFR2b Overexpressed Untreated Advanced Gastric and Gastroesophageal Junction Cancer.TerminatedNCT05111626Phase 3
- Camrelizumab Plus Pyrotinib Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) AdenocarcinomaStatus unknownNCT05111444Phase 2
- A Pilot Study of Neoadjuvant Chemotherapy With or Without Camrelizumab for Locally Advanced Gastric CancerSuspendedNCT05101616Phase 1/2
- Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric CancerStatus unknownNCT05095636Phase 2
- A Study of Anvumetostat in Participants With Advanced MTAP-null Solid Tumors (MTAPESTRY 101)Active, not recruitingNCT05094336Phase 1/2
- GLIM-defined Malnutrition Criteria for Postoperative Outcomes in Patients With Esophagogastric CancerCompletedNCT05088304
- Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative ChemotherapyCompletedNCT05083338
- IMM2902, a HER2/SIRPα Bispecific MAb-Trap Antibody-receptor Fusion Protein, in Patients with HER2-expressing Advanced Solid TumorsSuspendedNCT05076591Phase 1
- Safety and Efficacy of Single or Reduced Ports Laparoscopic Gastrectomy for Advanced Gastric Cancer (SPACE-01)Active, not recruitingNCT05076279Not applicable
- Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid TumorsActive, not recruitingNCT05075993Phase 1
- Prognostic Values of Inflammation-based Indices in Gastric CancerCompletedNCT05075421
- Gastrectomy Outcomes in Elderly PatientsStatus unknownNCT05071755
- Camrelizumab Combined With Chemotherapy in First-line Treatment of HER2-positive Gastric CancerStatus unknownNCT05070598Phase 2
- Evaluation of the Efficacy of Distal Gastrectomy for the Treatment of Gastric Cancer (a Case Series)CompletedNCT05068635
- Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly PatientsStatus unknownNCT05068180Phase 4
- Genomic Evolution of Metastasis in Gastric CancerStatus unknownNCT05061082